Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07078240Not ApplicableNot Yet Recruiting

Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender

Role: collaborator

NCT06363253Recruiting

Pilot Study of the Human Metagenome in Metabolic Diseases

Role: collaborator

NCT06540001Not ApplicableNot Yet Recruiting

Development and Validation of an Automated Self-administered Visual Acuity System

Role: collaborator

NCT02776397Not ApplicableUnknown

Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial

Role: collaborator

All 4 trials loaded